12 18

Cited 0 times in

조혈모세포 이식 후 발생한 간정맥폐색성 질환에서 Tissue Plasminogen Activator의 치료 효과

Other Titles
 Therapeutic Effect of Tissue Plasminogen Activator in Hepatic Veno-occlusive Disease after Hematopoietic Stem Cell Transplantation 
Authors
 정소영  ;  한지숙  ;  민유홍  ;  이승태  ;  김성철  ;  고윤웅 
Citation
 대한조혈모세포이식학회지, Vol.3(2) : 221-232, 1998 
Journal Title
 대한조혈모세포이식학회지 
ISSN
 1598-6039 
Issue Date
1998
Abstract
Background : Hepatic veno-occlusive disease (VOD) is one of the major morbidity and mortality after hematopoietic stem cell transplantation. It has been shown that thrombolytic therapy using recombinant human tissue plasminogen activator (tPA) is a promising specific treatment for this potentially fatal complications. We evaluated clinical characteristics of patients with VOD, clinical manifestations and therapeutic response of VOD to tPA in our transplant patients. Methods : 73 cases received hematopoietic stem cell transplantation during 6-year period from December 1991. Pentoxifylline and low dose heparin infusion were used as a Preventive measure of VOD. Results : Hepatic reno-occlusive disease has occurred in 10 cases (7 moderate, 3 severe). The incidence was 17.5% in hematologic malignancy and 0% in severe aplastic anemia (p=0.071). Busulfan plus cyclophosphamide conditioning was associated with significant VOD risk (p=0.001). All VOD patients were treated with tPA (10-25 mg/d for 4 days) and successful resolution was achieved in 70% of patients without significant bleeding complications. Conclusion : Hepatic VOD can be successfully treated with tPA in significant proportion of cases. VOD cases with severe manifestations should be treated early in the course of the disease.
Files in This Item:
T199801134.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Min, Yoo Hong(민유홍) ORCID logo https://orcid.org/0000-0001-8542-9583
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/176361
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links